Elisabeth Sthengel
Directeur Technique/Scientifique/R&D chez INVENT MEDIC SWEDEN AB
Profil
Elisabeth Sthengel is currently working as Manager-Design, Development & Clinical at Invent Medic Sweden AB since 2017.
Prior to this, she worked as Laboratory Manager at NOLabs AB.
Postes actifs de Elisabeth Sthengel
| Sociétés | Poste | Début |
|---|---|---|
| INVENT MEDIC SWEDEN AB | Directeur Technique/Scientifique/R&D | 01/06/2017 |
Anciens postes connus de Elisabeth Sthengel
| Sociétés | Poste | Fin |
|---|---|---|
NOLabs AB
 NOLabs AB Medical SpecialtiesHealth Technology NOLabs AB is a holding company that explores and develops proprietary therapies for diabetic patients where current treatment options are insufficient or complicated. It is a medical device company that focuses on its core technology, as well as the development of therapeutic applications for diabetic pain relief. Its product contains NitroSense Nitric Oxide (NO) delivery system and is a multilayer patch that is designed to release NO in a controlled manner. The firm core concept of NitroSense Technology is combining a substance and a delivery system to create h products for local delivery of NO. The company was founded in 2004 and is headquartered in Helsingborg, Sweden. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INVENT MEDIC SWEDEN AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
NOLabs AB
NOLabs AB Medical SpecialtiesHealth Technology NOLabs AB is a holding company that explores and develops proprietary therapies for diabetic patients where current treatment options are insufficient or complicated. It is a medical device company that focuses on its core technology, as well as the development of therapeutic applications for diabetic pain relief. Its product contains NitroSense Nitric Oxide (NO) delivery system and is a multilayer patch that is designed to release NO in a controlled manner. The firm core concept of NitroSense Technology is combining a substance and a delivery system to create h products for local delivery of NO. The company was founded in 2004 and is headquartered in Helsingborg, Sweden. | Health Technology |
